6/7/2019 8:05:20 AM
Aurinia Pharma Recommends Shareholders Vote The YELLOW Proxy “FOR” All Of Qualified Nominees
9/25/2018 4:14:45 PM
Urinia Completes Enrollment Of AURORA, Its Phase 3 Clinical Trial For The Treatment Of Lupus Nephritis
6/25/2018 7:03:16 AM
Aurinia Pharma Says First Lupus Nephritis Patients Roll Over Into AURORA 2 Extension Study; Begins Phase II FSGS Trial
2/8/2018 6:14:48 AM
RBC Capital Markets Starts Aurinia Pharmaceuticals Inc. (AUPH) At Outperform With $9 Price Target